UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________

 

FORM 8-K

_________________________

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported):   January 6, 2017

 

_________________________

 

NEXEON MEDSYSTEMS INC

(Exact Name of Registrant as Specified in Charter)

 

 

Nevada   000-55655   81-0756622
(State or Other Jurisdiction   (Commission File Number)   (IRS Employer
of Incorporation)       Identification No.)

 

 

 

1708 Jaggie Fox Way

Lexington, Kentucky

  40511  
  (Address of Principal Executive Offices)   (Zip Code)  

 

 

844-919-9990

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

_________________________

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).

 

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).

 

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).

 

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

 

1
 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

Stock Exchange Agreement

 

On January 6, 2017, (the "Effective Date), Nexeon MedSystems Inc (“Nexeon”), and Rosellini Scientific LLC, a Texas limited liability company ("RS"), entered into a Stock Exchange Agreement (the “Agreement”). Subject to the terms and conditions set forth the Agreement, on the Effective Date, RS sold, transferred, and assigned to Nexeon all of its right, title and interest in and to 100 shares of common stock of MicroTransponder Inc., a Delaware corporation (the "MTI Shares") in exchange for 591 shares of common stock of Emeritus Clinical Solutions, Inc. (formerly Telemend, Inc.), a Texas corporation, owned by Nexeon and Nexeon sold, transferred and assigned to RS 591 shares of common stock of Emeritus Clinical Solutions, Inc. (the “Emeritus Shares”) in exchange for the 100 MTI Shares (the MTI Shares and Emeritus Shares are collective referred to as the “Exchange Shares”). The value of the Emeritus Shares on the books of Nexeon as of the Effective Date was $120,611.

 

The Exchange Shares were duly authorized, validly issued, fully paid, and non-assessable, and were owned of record and beneficially by RS and Nexeon, free and clear of all liens, pledges, security interests, charges, claims, encumbrances, agreements, options, voting trusts, proxies, and other arrangements or restrictions of any kind (“Liens”). Upon consummation of the transactions pursuant to the Agreement, Nexeon owns the MTI Shares free and clear of any and all Liens and RS owns the Emeritus Shares free and clear of any and all Liens.

 

Nexeon acquired the MTI Shares solely for its own account for investment purposes and not with a view to, or for offer or sale in connection with, any distribution thereof. Nexeon acknowledges that the MTI Shares are not registered under the Securities Act of 1933, as amended, or any state securities laws, and that the MIT Shares may not be transferred or sold except pursuant to the registration provisions of the Securities Act of 1933, as amended or pursuant to an applicable exemption there from and subject to state securities laws and regulations, as applicable.

 

The foregoing description of the terms of the Stock Exchange Agreement does not purport to be complete and is subject to and qualified in its entirety by reference to the agreement itself, a copy of which is filed as Exhibit 10.1 to this report, and the terms of which are incorporated herein by reference. 

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit No.   Description
     
10.1   Stock Exchange Agreement between Rosellini Scientific, LLC and Nexeon Medsystems Inc

 

 

2
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  NEXEON MEDSYSTEMS INC
   
   
  By: /s/ Ronald Conquest
Date:   January 19, 2017   Ronald Conquest
   

Executive Vice President of Finance

 

3
 

 

EXHIBIT 10.1

 

STOCK EXCHANGE AGREEMENT

 

THIS STOCK EXCHANGE AGREEMENT (the "Agreement"), dated as of January 6, 2017, (the " Effective Date ) , is entered into by and between Nexeon MedSystems Inc (“Nexeon”), a Nevada corporation located at 1708 Jaggie Fox Way, Lexington, Kentucky 40511 , and Rosellini Scientific LLC , a Texas limited liability company ( "RS" ) , locat ed at 17217 Waterview Pkwy, Dallas , Texas 75252 , hereinafter collectively Nexeon and RS shall be known as (the “ Parties” )

 

RECITALS

 

WHEREAS, RS owns 100 shares of Common Stock of MicroTransponder Inc., a Delaware corporation (the "MTI Shares "); and

 

WHEREAS, Nexeon desires to acquire the MTI Shares from RS and RS is willing to transfer the MTI Shares to Nexeon in exchange for Emeritus Clinical Solutions, Inc. (formerly Telemend, Inc.), a Texas corporation, shares of common stock ( the “Emeritus Shares”) owned by Nexeon;

 

NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

AGREEMENT

 

1.        Transfer and Exchange . Subject to the terms and conditions set forth herein , on the Effective Date, RS shall sell, transfer , and assign to Nexeon all of its rights, title and interest in and to the 100 MTI Shares , and in exchange Nexeon shall sell, transfer and assign to RS all of its rights, title, and interest in and to 591 Emeritus Shares (collectively the “Exchange Shares”) .

 

2.        Closing . Subject to the terms and conditions contained in this Agreement, the transfer and exchange of the Exchange Shares contemplated her eby s hall take place on the Effective Dat e at which time RS shall deliver to Nexeon a stock certificate or certificates evidencing the MTI Shares, free and clear of all Liens (as defined herein) , and Nexeon shall deliver to RS a stock certificate or certificates evidencing the Emeritus Shares, free and clear of all Liens (as defined herein).

 

3.        Closing Conditions

 

The obligation of the Parties to sell, transfer, and assign the Exchanged Shares each to the other hereunder is subject to the satisfaction of the following conditions as of the Effective Date:

 

A. the representations and warranties of the Parties herein shall be true and correct on and as of the Effective Date; and

 

B. the Parties shall have performed and complied in all material respects with all agreements and conditions required by this Agreement to be performed or complied with by it prior to or on the Effective Date; and

 

 

1
 

 

C. the Parties shall have obtained any and all consents, permits, approvals, registrations, and waivers necessary or appropriate for the execution of this Agreement and the consummation of the transactions contemplated hereby.

 

4.        Representations, Warranties, and Covenants of RS . RS hereby represents, warrants, and covenants to Nexeon as follows:

 

A. RS is a limited liability company duly organized, validly existing, and in good standing under the laws of the State of Texas.

 

B. RS has all requisite power and authority to execute and deliver this Agreement, to carry out its obligations hereunder, and to consummate the transactions contemplated hereby. RS has obtained all necessary limited liability company approvals for the execution and delivery of this Agreement, the performance of its obligations hereunder, and the consummation of the transactions contemplated hereby. This Agreement has been duly executed and delivered by RS and (assuming due authorization, execution and delivery by Nexeon) constitutes RS’s legal, valid, and binding obligation, enforceable against RS in accordance with its terms.

 

C. The MTI Shares have been duly authorized, are validly issued, fully paid, and non-assessable, and are owned of record and beneficially by RS, free and clear of all liens, pledges, security interests, charges, claims, encumbrances, agreements, options, voting trusts, proxies, and other arrangements or restrictions of any kind (“ Liens ”), including but not limited to Liens of any applicable taxing authority. Upon consummation of the transactions contemplated by this Agreement, Nexeon shall own the MTI Shares free and clear of any and all Liens.

 

D. The execution, delivery, and performance by RS of this Agreement do not conflict with, violate or result in the breach of, or create any Lien on the MTI Shares pursuant to any agreement, instrument, order, judgment, decree, law, or governmental regulation to which RS is a party or is subject or by which the MTI Shares are bound, other than State and Federal Securities laws, rules, and regulations.

 

E. No governmental, administrative, or other third-party consents or approvals are required by or with respect to the Company in connection with the execution and delivery of this Agreement and the consummation of the transactions contemplated hereby.

 

F. There are no actions, suits, claims, investigations, or other legal proceedings pending or, to the knowledge of RS, threatened against or by RS that challenge or seek to prevent, enjoin, or otherwise delay the transactions contemplated by this Agreement.

 

G. No broker, finder, or investment banker is entitled to any brokerage, finder, or other fee or commission in connection with the transactions contemplated hereby based upon arrangements made by or on behalf of RS.

 

 

2
 

 

5.        Representation, Warranties, and Covenants of Nexeon . Nexeon hereby represents, warrants, and covenants to RS as follows:

 

A. Nexeon is a corporation duly organized, validly existing, and in good standing under the laws of the State of Nevada.

 

B. Nexeon has all requisite power and authority to enter into this Agreement, to carry out its obligations hereunder, and to consummate the transactions contemplated hereby. The execution and delivery by Nexeon of this Agreement, the performance by Nexeon of its obligations hereunder, and the consummation by Nexeon of the transactions contemplated hereby have been duly authorized by all requisite corporate action on the part of Nexeon. This Agreement has been duly executed and delivered by Nexeon, and (assuming due authorization, execution, and delivery by RS) this Agreement constitutes a legal, valid, and binding obligation of Nexeon enforceable against Nexeon in accordance with its terms.

 

C. The Emeritus Shares have been duly authorized, are validly issued, fully paid, and non-assessable, and are owned of record and beneficially by Nexeon, free and clear of all liens, pledges, security interests, charges, claims, encumbrances, agreements, options, voting trusts, proxies, and other arrangements or restrictions of any kind (“ Liens ”), including but not limited to Liens of any applicable taxing authority. Upon consummation of the transactions contemplated by this Agreement, RS shall own the Emeritus Shares free and clear of any and all Liens.

 

D. Nexeon is acquiring the MTI Shares solely for its own account for investment purposes and not with a view to, or for offer or sale in connection with, any distribution thereof. Nexeon acknowledges that the MTI Shares are not registered under the Securities Act of 1933, as amended, or any state securities laws, and that the MTI Shares may not be transferred or sold except pursuant to the registration provisions of the Securities Act of 1933, as amended or pursuant to an applicable exemption there from and subject to state securities laws and regulations, as applicable.

 

E. There are no actions, suits, claims, investigations, or other legal proceedings pending or, to the actual knowledge of Nexeon, threatened against or by Nexeon that challenge or seek to prevent, enjoin, or otherwise delay the transactions contemplated hereby.

 

F. No broker, finder, or investment banker is entitled to any brokerage, finder, or other fee or commission in connection with the transactions contemplated by this Agreement based upon arrangements made by or on behalf of Nexeon.

 

6.        Legend . The Parties understand that the Exchanged Shares shall bear the following legend:

 

THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE ENACTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.

 

3
 

 

7.        Survival . All representations, warranties, and covenants contained herein shall survive the execution and delivery of this Agreement.

 

8.        Indemnification . The Parties hereto shall each indemnify the other and hold each other harmless against and in respect of any and all losses, liabilities, damages, obligations, claims, Liens, costs, and expenses (including, without limitation, reasonable attorneys’ fees) incurred by the other resulting from any breach of any representation, warranty, covenant, or agreement made herein or in any instrument or document delivered pursuant hereto.

 

9.        Further Assurances . Following the Effective Date, each of the Parties hereto shall execute and deliver such additional documents, instruments, conveyances, and assurances and take such further actions as may be reasonably required to carry out the provisions hereof and give effect to the transactions contemplated hereby.

 

10.        Confidentiality . Each of the Parties hereto acknowledge and agree that this Agreement is confidential, and no party shall disclose this Agreement or any terms hereof to any third parties, except as may be necessary to obtain advice and counseling from such party’s attorneys, accountants, or financial advisors or as may otherwise be required through legal process.

 

11.        Expenses . All costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such costs and expenses.

 

12.        Notices . All notices, requests, consents, claims, demands, waivers, and other communications hereunder (each, a “ Notice ”) shall be in writing and addressed to the Parties at the addresses set forth on the first page of this Agreement (or to such other address that may be designated by the receiving party from time to time in accordance with this section). All Notices shall be delivered by personal delivery, nationally recognized overnight courier (with all fees pre-paid), facsimile or e-mail of a PDF document (with confirmation of transmission) or certified or registered mail (in each case, return receipt requested, postage prepaid). Except as otherwise provided for in this Agreement, a Notice is effective only if, (a) upon receipt by the receiving party; and (b) the party giving the Notice has complied with the requirements of this Section 12.

 

13.        Entire Agreement . This Agreement, including all exhibits and schedules hereto, constitutes the sole and entire agreement of the Parties to this Agreement with respect to the subject matter contained herein and supersedes all prior and contemporaneous understandings, agreements, representations, and warranties (both written and oral) with respect to such subject matter.

 

14.        Successor and Assigns . This Agreement shall be binding upon and shall inure to the benefit of the Parties hereto and their respective successors and permitted assigns. No party may assign any of its rights or obligations hereunder without the prior written consent of the other Parties hereto, which consent shall not be unreasonably withheld or delayed; provided, however, that the Parties may assign any of its rights or obligations hereunder, in whole or in part, to an affiliate of the party without consent of the other party.

 

15.        Headings . The headings in this Agreement are for reference only and shall not affect the interpretation of this Agreement.

 

4
 

 

16.        Amendment and Modification; Waiver . This Agreement may only be amended, modified, or supplemented by an agreement in writing signed by each party hereto. No waiver by any party of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed by the party so waiving. Except as otherwise set forth in this Agreement, no failure to exercise, or delay in exercising, any rights, remedy, power, or privilege arising from this Agreement shall operate or be construed as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power, or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege.

 

17.        Severability . If any term or provision of this Agreement is invalid, illegal, or unenforceable in any jurisdiction, such invalidity, illegality, or unenforceability shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal, or unenforceable, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the greatest extent possible.

 

18.        Drafting Party . This Agreement expresses the mutual intent of the Parties, and accordingly any rule of construction against the drafting party will have no application to this Agreement.

 

19.        Governing Law; Submission to Jurisdiction . This Agreement shall be governed by and construed in accordance with the internal laws of the State of Texas without giving effect to any choice or conflict-of-law provision or rule. Any legal suit, action, or proceeding arising out of or based upon this Agreement or the transactions contemplated hereby may be instituted in the federal courts of the United States or the courts of the State of Texas in each case located in the city of Dallas and County of Dallas, and each party irrevocably submits to the exclusive jurisdiction of such courts in any such suit, action, or proceeding. Service of process, summons, notice, or other document by mail to such party’s address set forth herein shall be effective service of process for any suit, action, or other proceeding brought in any such court. The Parties irrevocably and unconditionally waive any objection to the laying of venue of any suit, action, or any proceeding in such courts and irrevocably waive and agree not to plead or claim in any such court that any such suit, action, or proceeding brought in any such court has been brought in an inconvenient forum.

 

20.        Counterparts . This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement. A signed copy of this Agreement delivered by facsimile, e-mail, or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Agreement.

 

5
 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement to be effective as of the date first above written herein.

 

 

ROSELLINI SCIENTIFIC LLC  
       
       
By: /s/ William Rosellini   Date:   January 6, 2017
William Rosellini, Manager    
   

 

NEXEON MEDSYSTEMS INC  
       
       
By: /s/ Ron Conquest   Date:   January 6, 2017
Ron Conquest, Executive VP of Finance    
   

 

 

6